Resources
Proteomics Databases
Metabolomics Databases
-
• Single Domain Antibody vs Nanobody: Method Selection and Research Use Cases
Technical guide for Single Domain Antibody vs Nanobody: Method Selection and Research Use Cases.
-
• Phage Display Antibody Analysis vs Mass Spectrometry: Method Selection and Research Use Cases
Technical guide for Phage Display Antibody Analysis vs Mass Spectrometry: Method Selection and Research Use Cases.
-
• Phage Display Antibody Analysis vs ELISA: Method Selection and Research Use Cases
Technical guide for Phage Display Antibody Analysis vs ELISA: Method Selection and Research Use Cases.
-
Technical guide for Disease Biomarker Discovery Antibody Analysis Troubleshooting: Causes, Checks, and Fixes for Research Workflows.
-
• How to Improve Disease Biomarker Discovery Antibody Analysis Optimization in Research Workflows
Technical guide for How to Improve Disease Biomarker Discovery Antibody Analysis Optimization in Research Workflows.
-
• How to Improve Antibody Diversity and Specificity Analysis Workflows
Technical guide for How to Improve Antibody Diversity and Specificity Analysis Workflows.
-
Technical guide for Antibody Diversity And Specificity Analysis vs Mass Spectrometry: Method Selection and Research Use Cases.
-
• HLA Peptidome Analysis Strategies in Personalized Cancer Immunotherapy
With the widespread application of immunotherapy in cancer treatment, strategies such as personalized tumor vaccines, TCR-T, and CAR-T therapies have become major research focuses. However, variability in therapeutic efficacy and the complexity of patient-specific immune responses have highlighted limitations in current precision immunotherapy approaches. In this context, HLA peptidome (immunopeptidome) analysis has emerged as a critical tool linking antigen processing with T cell recognition and is i......
-
• Advances in Immunopeptidomics Research in Autoimmune Diseases
Autoimmune diseases (AIDs) are a group of disorders in which the immune system aberrantly attacks self-tissues. Common types include systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and type 1 diabetes (T1D), among others. Although dysregulated immune regulatory mechanisms have been extensively investigated, the initiating event of immune recognition, antigenic peptide fragments presented by major histocompatibility complex (MHC) molecules, collectively referred to as the immunopeptidome......
-
• Edman Sequencing: When N-Terminal Residue Analysis Is Still the Right Choice
Protein characterization now offers many mass spectrometry-based options for sequence confirmation, peptide mapping, and de novo assembly. In that landscape, Edman sequencing can appear old-fashioned. Yet N-terminal residue analysis by Edman degradation remains a strong choice in many real projects because it answers a focused question with direct chemistry: what amino acids are present at the free N-terminus, in order, starting from cycle one?
How to order?
